From Financial Modeling Prep: 2025-01-07 12:08:00

BTIG analysts have initiated coverage of Hims & Hers Health (NYSE:HIMS) with a Buy rating and a price target of $35, citing the company’s innovative healthcare services and strong growth trajectory. Hims & Hers operates a direct-to-consumer model with over 2 million members, showing a 44% increase year-over-year. The company’s proprietary EMR system and affiliated pharmacies contribute to its comprehensive offerings and revenue growth potential. Positioned to capitalize on consumer healthcare trends, Hims & Hers is expected to sustain earnings power and expand market share in the direct-to-consumer health space.



Read more at Financial Modeling Prep:: Hims & Hers Coverage Initiated with Buy Rating on …